Target intelligence / Profile preview

Guanylate cyclase activator 1A (GUCA1A)

Target
GUCA1A
Molecular classification
Enzyme, Calcium-binding protein, EF-hand domain-containing protein
01

Overview

The entry "GUCA1ANB-GUCA1A readthrough" represents a naturally occurring readthrough transcript between the neighboring GUCA1ANB (GUCA1A neighbor) and GUCA1A genes on chromosome 6. This transcript encodes the same protein as GUCA1A, not a distinct functional product. GUCA1A encodes guanylate cyclase-activating protein 1 (GCAP1), a neuronal calcium sensor predominantly found in rod and cone photoreceptors. GCAP1 regulates the activity of retinal guanylyl cyclase (RetGC), promoting cGMP synthesis at low calcium concentrations and inhibiting it at high calcium concentrations, thus playing a central role in phototransduction and recovery of visual photoreceptors after light exposure. Pathogenic variants in GUCA1A are associated with inherited retinal degenerations, notably cone dystrophy 3 and cone-rod dystrophy 14. Disease-causing variants typically alter calcium sensitivity or guanylyl cyclase activation, resulting in photoreceptor cell dysfunction and degeneration[2][3][4][5][6]. Note: This specific "GUCA1ANB-GUCA1A" entity is not a distinct protein, but rather a readthrough transcript encoding canonical GUCA1A protein[5]. For all practical, functional, and therapeutic targeting purposes, only GUCA1A (GUCA1A/GCAP1) is the relevant molecule. The readthrough form is not considered a separate therapeutic target, and thus this target name is technically incorrect for structured purposes.

Other names
GCAP1guanylyl cyclase-activating protein 1guanylate cyclase activator 1A (retina)
02

Biological functions

PhototransductionCalcium sensingRegulation of cGMP synthesisVisual signal recovery
03

Disease associations

Cone dystrophyCone-rod dystrophyRetinal degeneration
04

Safety considerations

Mutations may lead to toxic accumulation of cGMP and Ca²⁺, triggering photoreceptor cell death[2][3]
05

Biomarkers

Variants in GUCA1A can serve as biomarkers for cone dystrophy 3 and cone-rod dystrophy 14[2][6]

Beyond the preview

Go deeper on Guanylate cyclase activator 1A (GUCA1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanylate cyclase activator 1A (GUCA1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call